Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 2/20 | 0.56 |
| ▸ | P2RY12 known ✓ | Q9H244 | 6/20 | 0.55 |
| ▸ | P2RY4 known ✓ | P51582 | 6/20 | 0.55 |
| ▸ | P2RY2 known ✓ | P41231 | 4/20 | 0.55 |
| ▸ | P2RY1 known ✓ | P47900 | 2/20 | 0.55 |
| ▸ | P2RY6 known ✓ | Q15077 | 2/20 | 0.55 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.61 |
| ▸ | MAOA | P21397 | 1/20 | 0.59 |
| ▸ | MAOB | P27338 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2926956 | 0.81 | PKLR (0.54) | FTOMAOAMAOBALDH1A1MAPK1 | |
| SCHEMBL626587 | 0.81 | ALDH1A1 (0.62) | MAOAMAOBALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL8193493 | 0.80 | ALDH1A1 (0.60) | MAOAMAOBALDH1A1MAPK1L3MBTL1 | |
| Sulfuric Acid SCHEMBL28152379 | 0.80 | ALDH1A1 (0.60) | MAOAMAOBALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL27460699 | 0.80 | FTO (0.54) | FTOMAOAMAOBALDH1A1MAPK1 | |
| SCHEMBL1412691 | 0.79 | ALDH1A1 (0.59) | FTOALDH1A1MAPK1L3MBTL1MEN1 | |
| SCHEMBL29622863 | 0.79 | ALDH1A1 (0.59) | FTOALDH1A1MAPK1L3MBTL1MEN1 | |
| SCHEMBL31317955 | 0.79 | ALDH1A1 (0.59) | FTOALDH1A1MAPK1L3MBTL1MEN1 | |
| SCHEMBL14988941 | 0.78 | ADORA2A (0.66) | FTOMAOAMAOBALDH1A1MAPK1 | |
| SCHEMBL11049644 | 0.78 | PKLR (0.51) | FTOMAOAMAOBALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119290855-A | Water hardness test paper and preparation method thereof | 上海三爱思试剂有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-107488359-A | Polyether amine chain segment-containing blue acid dye and preparation method thereof | 南京工业大学 | 2017-12-19 | — | — | CN | claimed |
| CN-107488358-A | Acid dye for low-temperature dyeing of wool and preparation method thereof | 南京工业大学 | 2017-12-19 | — | — | CN | claimed |
| US-6165341-A | Catalytic film, methods of making the catalytic films, and electrosynthesis of compounds using the catalytic film | SACHEM, INC. (US) | 2000-12-26 | — | — | US | claimed |
| EP-1021595-A2 | ELECTROSYNTHESIS OF HYDROXYLAMMONIUM SALTS AND HYDROXYLAMINE USING A MEDIATOR, A CATALYTIC FILM, METHODS OF MAKING THE CATALYTIC FILM, AND ELECTROSYNTHESIS OF COMPOUNDS USING THE CATALYTIC FILM | SACHEM, INC. (US) | 2000-07-26 | — | — | EP | claimed |
| US-6024855-A | Electrosynthesis of hydroxylammonium salts and hydroxylamine using a mediator | SACHEM, INC. (US) | 2000-02-15 | — | — | US | claimed |
| WO-1999009234-A2 | ELECTROSYNTHESIS OF HYDROXYLAMMONIUM SALTS AND HYDROXYLAMINE USING A MEDIATOR, A CATALYTIC FILM, METHODS OF MAKING THE CATALYTIC FILM, AND ELECTROSYNTHESIS OF COMPOUNDS USING THE CATALYTIC FILM | SACHEM, INC. (US) | 1999-02-25 | — | — | WO | claimed |
| CN-119290855-A | Water hardness test paper and preparation method thereof | 上海三爱思试剂有限公司 | 2025-01-10 | — | — | CN | disclosed |
| US-20180036995-A1 | HYDROPHILIC MONOLAYER FILM WITH OPTICAL FUNCTIONALITY AND STACK OF THE SAME | MITSUI CHEMICALS, INC. (JP) | 2018-02-08 | — | — | US | disclosed |
| EP-3270192-A1 | HYDROPHILIC SINGLE-LAYER FILM HAVING OPTICAL FUNCTIONALITY, AND LAMINATE THEREOF | Mitsui Chemicals, Inc. (JP) | 2018-01-17 | — | — | EP | disclosed |
| EP-2599799-B1 | SINGLE-LAYER FILM AND HYDROPHILIC MATERIAL COMPRISING SAME | MITSUI CHEMICALS INC (JP) | 2016-05-25 | — | — | EP | disclosed |
| US-9034464-B2 | Single layer film and hydrophilic material comprising the same | MITSUI CHEMICALS, INC. (JP) | 2015-05-19 | — | — | US | disclosed |
| US-20150126682-A1 | HYDROPHILIC MODIFIED ACRYLIC RESIN FILM | MITSUI CHEMICALS, INC. (JP) | 2015-05-07 | — | — | US | disclosed |
| US-20050049313-A1 | Electron mediator, electron mediator immobilized electrode, and biofuel cell using the electrode | DAIICHI PURE CHEMICALS CO., LTD. | 2005-03-03 | — | — | US | disclosed |
| US-6165341-A | Catalytic film, methods of making the catalytic films, and electrosynthesis of compounds using the catalytic film | SACHEM, INC. (US) | 2000-12-26 | — | — | US | disclosed |
| EP-1021595-A2 | ELECTROSYNTHESIS OF HYDROXYLAMMONIUM SALTS AND HYDROXYLAMINE USING A MEDIATOR, A CATALYTIC FILM, METHODS OF MAKING THE CATALYTIC FILM, AND ELECTROSYNTHESIS OF COMPOUNDS USING THE CATALYTIC FILM | SACHEM, INC. (US) | 2000-07-26 | — | — | EP | disclosed |
| US-6024855-A | Electrosynthesis of hydroxylammonium salts and hydroxylamine using a mediator | SACHEM, INC. (US) | 2000-02-15 | — | — | US | disclosed |
| WO-1999009234-A2 | ELECTROSYNTHESIS OF HYDROXYLAMMONIUM SALTS AND HYDROXYLAMINE USING A MEDIATOR, A CATALYTIC FILM, METHODS OF MAKING THE CATALYTIC FILM, AND ELECTROSYNTHESIS OF COMPOUNDS USING THE CATALYTIC FILM | SACHEM, INC. (US) | 1999-02-25 | — | — | WO | disclosed |
| US-4452742-A | Process for the preparation of 4,4'-diamino-1,1'-dianthrimides | BAYER AKTIENGESELLSCHAFT (DE) | 1984-06-05 | — | — | US | disclosed |
| US-4351765-A | Process for the production of compounds having in the molecule at least one β-sulfatoethyl-sulfone group and at least one sulfonic acid group | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050049313-A1 | Electron mediator, electron mediator immobilized electrode, and biofuel cell using the electrode | SQOR, ME3, VAT1 | THRB 4829/4885P2RY12 3550/4885P2RY4 3885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.